Background: Optimal blood pressure (BP) control remains elusive for millions of patients worldwide, often leading to resistant or secondary hypertension. Overactivation of the mineralocorticoid receptor (MR) drives this systemic pathology. While steroidal mineralocorticoid receptor antagonists (MRAs) are effective, the...
G. Marino, S. D. Di Fusco, E. Graziano et al.· Journal of Clinical Medicine· 0 citations
BACKGROUND
Nonstatin low-density lipoprotein (LDL)-cholesterol-lowering therapies are increasingly used in secondary prevention, familial hypercholesterolemia, and statin-intolerant patients, but adverse-event reporting is heterogeneous, and harmonized safety evidence remains limited.
OBJECTIVE
To evaluate the tolera...
A. Matteucci, M. Bonanni, S. D. Di Fusco et al.· Journal of Clinical Lipidolo...· 0 citations
Overall, current evidence supports the technical efficacy of the WCD for terminating sustained ventricular tachyarrhythmias, but observational shock rates do not establish a population-level survival benefit.
A. Matteucci, M. Bonanni, M. Mariani et al.· Diagnostics· 0 citations
Findings should be interpreted cautiously and viewed as consistent with, rather than definitive evidence of, an association between particulate exposure and arrhythmia-related events.
A. Matteucci, Luca Sgarra, M. Bonanni et al.· Heart Rhythm· 1 citation· ⚡1
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.